CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

NCT03393611 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Leukemia, Relapsed Adult Acute Myeloid
Myelodysplastic Syndromes, Previously Treated

Interventions

DRUG: CPX-351
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Rabbit Anti-Human T-Lymphocyte Globulin
BIOLOGICAL: Haplo-Cord Stem Cell Transplantation

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]